Skip to Content

M LN3 (Lamivudine 300 mg)

Pill with imprint M LN3 is White, Elliptical / Oval and has been identified as Lamivudine 300 mg. It is supplied by Mylan Pharmaceuticals Inc..

Lamivudine is used in the treatment of hepatitis b; nonoccupational exposure; occupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M LN3

Lamivudine 300 mg M LN3

Lamivudine

Imprint:
M LN3
Strength:
300 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-5170

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide